These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 14871280)

  • 1. Sequential treatment for Helicobacter pylori does not share the risk factors of triple therapy failure.
    De Francesco V; Zullo A; Margiotta M; Marangi S; Burattini O; Berloco P; Russo F; Barone M; Di Leo A; Minenna MF; Stoppino V; Morini S; Panella C; Francavilla A; Ierardi E
    Aliment Pharmacol Ther; 2004 Feb; 19(4):407-14. PubMed ID: 14871280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prolongation of triple therapy for Helicobacter pylori does not allow reaching therapeutic outcome of sequential scheme: a prospective, randomised study.
    De Francesco V; Zullo A; Hassan C; Della Valle N; Pietrini L; Minenna MF; Winn S; Monno R; Stoppino V; Morini S; Panella C; Ierardi E
    Dig Liver Dis; 2004 May; 36(5):322-6. PubMed ID: 15191200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequential eradicating therapy: a treatment that does not discriminate Helicobacter pylori strains in patients with nonulcer dyspepsia?
    De Francesco V; Faleo D; Panella C; Ierardi E; Margiotta M
    Am J Gastroenterol; 2002 Oct; 97(10):2686-7. PubMed ID: 12385470
    [No Abstract]   [Full Text] [Related]  

  • 4. Effectiveness and pharmaceutical cost of sequential treatment for Helicobacter pylori in patients with non-ulcer dyspepsia.
    De Francesco V; Della Valle N; Stoppino V; Amoruso A; Muscatiello N; Panella C; Ierardi E
    Aliment Pharmacol Ther; 2004 May; 19(9):993-8. PubMed ID: 15113366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CagA status and Helicobacter pylori eradication among dyspeptic patients.
    Magalhães AF; Carvalhaes A; Natan-Eisig J; Paraíso-Ferraz JG; Trevisan M; Zaterkaad S
    Gastroenterol Hepatol; 2005 Oct; 28(8):441-4. PubMed ID: 16185577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sofalcone, a mucoprotective agent, increases the cure rate of Helicobacter pylori infection when combined with rabeprazole, amoxicillin and clarithromycin.
    Isomoto H; Furusu H; Ohnita K; Wen CY; Inoue K; Kohno S
    World J Gastroenterol; 2005 Mar; 11(11):1629-33. PubMed ID: 15786539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequential treatment for Helicobacter pylori eradication in duodenal ulcer patients: improving the cost of pharmacotherapy.
    Hassan C; De Francesco V; Zullo A; Scaccianoce G; Piglionica D; Ierardi E; Panella C; Morini S
    Aliment Pharmacol Ther; 2003 Sep; 18(6):641-6. PubMed ID: 12969091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 4-day triple therapy with rabeprazole, amoxicillin and clarithromycin in the eradication of Helicobacter pylori in patients with peptic ulcer disease--A pilot study.
    Lüth S; Teyssen S; Kölbel CB; Singer MV
    Z Gastroenterol; 2001 Apr; 39(4):279-81, 284-5. PubMed ID: 11367976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of rabeprazole-based four- and seven-day triple therapy and omeprazole-based seven-day triple therapy for Helicobacter pylori infection in patients with peptic ulcer.
    Yang KC; Wang GM; Chen JH; Chen TJ; Lee SC
    J Formos Med Assoc; 2003 Dec; 102(12):857-62. PubMed ID: 14976565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rabeprazole, amoxycillin and low- or high-dose clarithromycin for cure of Helicobacter pylori infection.
    Kihira K; Satoh K; Saifuku K; Kawakami S; Fukazawa K; Ishino Y; Kimura K; Sugano K
    Aliment Pharmacol Ther; 2000 Aug; 14(8):1083-7. PubMed ID: 10930904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A prospective study on rabeprazole-based triple therapy for Helicobacter pylori eradication in patients with peptic ulcer].
    Choi BK; Yang SY; Park ET; Jang YS; Lee YJ; Lee SH; Seol SY; Chung JM
    Korean J Gastroenterol; 2003 Aug; 42(2):102-7. PubMed ID: 14532713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparable Helicobacter pylori eradication rates obtained with 4- and 7-day rabeprazole-based triple therapy: a preliminary study.
    Gambaro C; Bilardi C; Dulbecco P; Iiritano E; Zentilin P; Mansia C; Usai P; Vigneri S; Savarino V
    Dig Liver Dis; 2003 Nov; 35(11):763-7. PubMed ID: 14674665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High rate of Helicobacter pylori eradication with sequential therapy in elderly patients with peptic ulcer: a prospective controlled study.
    Zullo A; Gatta L; De Francesco V; Hassan C; Ricci C; Bernabucci V; Cavina M; Ierardi E; Morini S; Vaira D
    Aliment Pharmacol Ther; 2005 Jun; 21(12):1419-24. PubMed ID: 15948808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent success of pantoprazole -or lansoprazole- based clarithromycin plus amoxicillin treatment in the eradication of Helicobacter pylori.
    Uygun A; Kadayifçi A; Yeşilova Z; Savaş MC; Ateş Y; Karslioğlu Y; Ciğerim M; Bağci S; Dağalp K
    Turk J Gastroenterol; 2004 Dec; 15(4):219-24. PubMed ID: 16249974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of 10-day sequential therapy with 7-day standard triple therapy for Helicobacter pylori eradication in inactive peptic ulcer disease and the efficiency of sequential therapy in inactive peptic ulcer disease and non-ulcer dyspepsia.
    Chan CC; Chien NH; Lee CL; Yang YC; Hung CS; Tu TC; Wu CH
    BMC Gastroenterol; 2015 Dec; 15():170. PubMed ID: 26635102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparison of Helicobacter pylori eradication rate in patients with non-ulcer dyspepsia and peptic ulcer diseases according to proton pump inhibitors].
    Hong EJ; Park DI; Oh SJ; Song MJ; Choi WH; Hong CH; Park JH; Kim HJ; Cho YK; Shon CI; Jeon WK; Kim BI
    Korean J Gastroenterol; 2008 Aug; 52(2):80-5. PubMed ID: 19077498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomised clinical trial: a comparative study of 10-day sequential therapy with 7-day standard triple therapy for Helicobacter pylori infection in naïve patients.
    Park HG; Jung MK; Jung JT; Kwon JG; Kim EY; Seo HE; Lee JH; Yang CH; Kim ES; Cho KB; Park KS; Lee SH; Kim KO; Jeon SW
    Aliment Pharmacol Ther; 2012 Jan; 35(1):56-65. PubMed ID: 22066530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High eradication rates of Helicobacter pylori with a new sequential treatment.
    Zullo A; Vaira D; Vakil N; Hassan C; Gatta L; Ricci C; De Francesco V; Menegatti M; Tampieri A; Perna F; Rinaldi V; Perri F; Papadìa C; Fornari F; Pilati S; Mete LS; Merla A; Potì R; Marinone G; Savioli A; Campo SM; Faleo D; Ierardi E; Miglioli M; Morini S
    Aliment Pharmacol Ther; 2003 Mar; 17(5):719-26. PubMed ID: 12641522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rabeprazole in a one-week eradication therapy of Helicobacter pylori: comparison of different dosages.
    Mario FD; Dal Bo N; Aragona G; Moussa AM; Iori V; Cavestro GM; Pilotto A; Leandro G; Franceschi M; Rugge M; Franze A
    J Gastroenterol Hepatol; 2003 Jul; 18(7):783-6. PubMed ID: 12795749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clarithromycin-resistant genotypes and eradication of Helicobacter pylori.
    De Francesco V; Margiotta M; Zullo A; Hassan C; Troiani L; Burattini O; Stella F; Di Leo A; Russo F; Marangi S; Monno R; Stoppino V; Morini S; Panella C; Ierardi E
    Ann Intern Med; 2006 Jan; 144(2):94-100. PubMed ID: 16418408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.